Dr. Curtis supports the overall commercialization process, including identification of companies for i2E’s advisory services and navigating them through the high-growth development process. These services include development and review of business strategies, working with clients to develop competitor analysis and identify competitive advantages, assisting in valuation, and preparing investor presentations. Curtis will also model financial projections and facilitate access to angel and/or venture capital markets.
Prior to joining i2E, Curtis was the founder, lead consultant and managing partner for C^2 Consulting LLC in Oklahoma City, where she worked closely with i2E clients Agric-Bioinformatics and Accele BioPharma, as well as the University of Oklahoma Health Sciences Center’s Office of Technology Development. Before that, Curtis spent two years with EpimedX LLC, where she was the associate director of research and development. Curtis also spent time as a consultant for TreMonti Consulting in Oakton, Virginia and was an i2E Venture Development Fellow in 2012.
Curtis received her bachelor’s in biochemistry from the University of Illinois at Urbana-Champaign, and her masters and doctorate in molecular and integrative physiology from the University of Illinois. Before joining EpimedX, Curtis was a postdoctoral associate research scientist for the Oklahoma Medical Research Foundation (OMRF). She also has continued education in project management, bioscience business and biotechnology entrepreneurship, as well as advanced training in building start-ups. Curtis has published numerous peer-reviewed papers and sits on several advisory boards.